Timing and location dictate monocyte fate and their transitions..! Congratulations Garett Dunsmore @realFlorentGinhoux and the entire team..!! Such a fascinating story..!

Today is World Hepatitis Day– a day to raise global awareness of hepatitis and encourage prevention, diagnosis, and treatment. NHMRC is proud of its funding investment into hepatitis research, committing $104 million over the past 10 years #TakeActionAustralia #WorldHepatitisDay

Do grant proposal texts matter for funding decisions? No they don't link.springer.com/article/10.100…

New research identifies an intermediate population of tumor-associated macrophages (TAMs) that give rise to more specialized TAMs in #PancreaticCancer. Read more in Science Immunology: scim.ag/7Sg

Dr. Hayflick discovered the Hayflick limit: that normal human cells have a finite number of divisions before they stop. This challenged the then-prevailing belief that cells could divide indefinitely

Happy to see our work, Nova-ST, a new open-source platform for high-resolution spatial transcriptomics published in Cell Cell Reports Methods cell.com/cell-reports-m… 👇

Recently published: Yttrium-90 Induces an Effector Memory Response with Neoantigen Clonotype Expansion: Implications for Immunotherapy, by Kelley Nunez et al. bit.ly/3WE4ZJ0 Ochsner Health UQ News #openaccess

Exciting #PhD Opportunity🚀 Are u interested in exploring secrets of #Microbiome & role in #ImmuneSystem development 🔬 Join us in our pioneering research ⁦University of Sydney⁩ ⁦Mishra Lab⁩🧑‍🔬 Apply now & reach out to me if u ready for this thrill 🧬🥼 sydney.edu.au/scholarships/c…

Thrilled to finally share an amazing discovery made during my PhD Kivanc Birsoy's lab. We found that glycosphingolipids in the plasma membrane of cancer cells impact how sensitive they are to immune cells. nature.com/articles/s4158…

We are pleased to share publication in Journal for ImmunoTherapy of Cancer EphA3 CAR T cell therapy for brain cancer. shorturl.at/xTI5v QIMR Berghofer Medical Research Institute MarkHughesFoundation BrainCancerCentre carriesbeanies4BC COGNO Brain Tumour Research Cure Brain Cancer #braincancer #immunotherapy

Is there a NanoString / Bruker FAS that is willing to help us in Australia? We have an issue with a CosMx run we just set and no one picks up the phone here in APAC and we have a run ready to go. If you know of someone please tell them to reach out to me. Thanks!

Beautiful work from Leila Akkari & Daan J. Kloosterman on Macrophage-mediated myelin recycling fuels brain cancer malignancy Cell #TAMs

Please RT! 🧬🧬 I am looking for a #postdoc fellow to lead a new project in 3D chromatin organisation and transcriptional regulation in cancer (experimental and/or computational) at South Australian immunoGENomics Cancer Institute in Adelaide. Apply below: careers.adelaide.edu.au/cw/en/job/5146…

Today's #FridayRead explores the tumor microenvironment of a liver cancer tissue section, with focus on the immune landscape. ➡️ rarecyte.com/pdf/AACR2024/7… Images courtesy of Ankur Sharma. This whole slide was stained & imaged in one scan using Orion. #LiverCancer #RareCyte

Shared developmental origins of the kidney and inner ear. go.nature.com/4csQSMD

We are announcing the 2024 Illumina #Epigenetics Research Grant Contest. The prize, valued at >$100K, is 1008 samples of the Methylation Screening Array Kit! Submit ideas by Oct 20th illumina.com/techniques/mic…

We are humbled to have our lab's work featured this week on the cover of nature (below), with many, many people to thank. First, the stellar crew of Inspiration4, Jared Isaacman, Hayley Arceneaux, Chris “Hanks” Sembroski 🇺🇦, Dr. Sian “Leo” Proctor, who donated time, blood, fluids, and sweat for

Happy to see our work describing the impact of the stressed tumor microenvironment on immune cells functionality, published today in Nature Cell Biology with Kate Hockemeyer, Iannis Aifantis and co-authors! Many thanks to the editorial team and reviewers! nature.com/articles/s4155…

Excited to see EACR picking our Nature Cancer article on implications of #oncofetal signatures to stratify HCC patients. Next, we are systematically evaluating this in a phase-II clinical trial funded by NHMRC magazine.eacr.org/highlights-in-…

Beautiful paper in @ScienMagazine from Miriam Merad, MD, PhD & co on aged immune microenvironment, TAMs reprogramming and its impact on cancer progression and recurrence science.org/doi/10.1126/sc…